サマリー

市場の分析と洞察。インフルエンザワクチンの世界市場
COVID-19のパンデミックにより、インフルエンザワクチンの世界市場規模は2022年に8036百万米ドルと推定され、レビュー期間中にCAGR5.3％で2028年までに10952百万米ドルに再調整されると予測されています。

インフルエンザワクチンの世界的な主要メーカーは、CSL、GSK、Sanofi、Viatris、Hualan Bio、AstraZeneca、Changchun Institute of Biologicalなどです。2021年、世界の上位5社の売上高シェアは約85.04％です。

世界のインフルエンザワクチンの範囲とセグメント
インフルエンザワクチン市場は、タイプ別、用途別に分類されます。世界のインフルエンザワクチン市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができます。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てます。

企業別
サノフィ
シーエスエル
GSK
ビアトリス
アストラゼネカ
花蘭バイオ
長春生物学研究所
シノベイト
BCHT
江蘇省GDK
KMバイオロジックス

種類別セグメント
3価インフルエンザワクチン
4価インフルエンザワクチン

用途別セグメント
小児用（6ヶ月～3歳）
成人および3歳以上の小児用

地域別セグメント
北米
米国
カナダ
メキシコ

アジア・パシフィック
中国
日本
韓国
インド
オーストラリア
東南アジア

欧州
ドイツ
フランス
英国
イタリア
ロシア

南米
ブラジル

中東・アフリカ
中東
アフリカ

ページTOPに戻る

目次

1 STUDY COVERAGE 1
1.1 Influenza Vaccine Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1
1.2.2 Trivalent Influenza Vaccine 3
1.2.3 Quadrivalent Influenza Vaccine 4
1.3 Market by Application 5
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 5
1.3.2 For Children (6 months to 3 years) 7
1.3.3 For Adults and Children over 3 years 8
1.4 Study Objectives 8
1.5 Years Considered 9
2 EXECUTIVE SUMMARY 10
2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2017-2028 10
2.2 Global Influenza Vaccine Revenue Estimates and Forecasts 2017-2028 11
2.3 Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028 12
2.4 Global Influenza Vaccine Sales by Region 14
2.4.1 Global Influenza Vaccine Sales by Region (2017-2022) 14
2.4.2 Global Sales Influenza Vaccine by Region (2023-2028) 15
2.5 Global Influenza Vaccine Revenue by Region 16
2.5.1 Global Influenza Vaccine Revenue by Region (2017-2022) 16
2.5.2 Global Influenza Vaccine Revenue by Region (2023-2028) 17
2.6 North America 18
2.7 Europe 19
2.8 Asia-Pacific 20
2.9 South America 21
2.10 Middle East & Africa 22
3 COMPETITION BY MANUFACTURERS 23
3.1 Global Influenza Vaccine Sales by Manufacturers 23
3.1.1 Global Influenza Vaccine Sales by Manufacturers (2020-2022) 23
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturers (2020-2022) 24
3.1.3 Global Top Largest Manufacturers of Influenza Vaccine in 2021 24
3.2 Global Influenza Vaccine Revenue by Manufacturers 25
3.2.1 Global Influenza Vaccine Revenue by Manufacturers (2020-2022) 25
3.2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2020-2022) 26
3.2.3 Global Top Companies by Influenza Vaccine Revenue in 2021 27
3.3 Global Influenza Vaccine Sales Price by Manufacturers (2020-2022) 27
3.4 Analysis of Competitive Landscape 28
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 28
3.4.2 Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) 29
3.4.3 Global Influenza Vaccine Manufacturers Geographical Distribution 30
3.5 Mergers & Acquisitions, Expansion Plans 31
4 MARKET SIZE BY TYPE 35
4.1 Global Influenza Vaccine Sales by Type 35
4.1.1 Global Influenza Vaccine Historical Sales by Type (2017-2022) 35
4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2023-2028) 35
4.1.3 Global Influenza Vaccine Sales Market Share by Type (2017-2028) 35
4.2 Global Influenza Vaccine Revenue by Type 36
4.2.1 Global Influenza Vaccine Historical Revenue by Type (2017-2022) 36
4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2023-2028) 37
4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2017-2028) 37
4.3 Global Influenza Vaccine Price by Type 38
4.3.1 Global Influenza Vaccine Price by Type (2017-2022) 38
4.3.2 Global Influenza Vaccine Price Forecast by Type (2023-2028) 38
5 MARKET SIZE BY APPLICATION 39
5.1 Global Influenza Vaccine Sales by Application 39
5.1.1 Global Influenza Vaccine Historical Sales by Application (2017-2022) 39
5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2023-2028) 39
5.1.3 Global Influenza Vaccine Sales Market Share by Application (2017-2028) 39
5.2 Global Influenza Vaccine Revenue by Application 40
5.2.1 Global Influenza Vaccine Historical Revenue by Application (2017-2022) 40
5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2023-2028) 41
5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2017-2028) 41
5.3 Global Influenza Vaccine Price by Application 42
5.3.1 Global Influenza Vaccine Price by Application (2017-2022) 42
5.3.2 Global Influenza Vaccine Price Forecast by Application (2023-2028) 42
6 NORTH AMERICA 43
6.1 North America Influenza Vaccine Market Size by Type 43
6.1.1 North America Influenza Vaccine Sales by Type (2017-2028) 43
6.1.2 North America Influenza Vaccine Revenue by Type (2017-2028) 44
6.2 North America Influenza Vaccine Market Size by Application 45
6.3 North America Influenza Vaccine Sales by Country 46
6.3.1 North America Influenza Vaccine Sales by Country (2017-2028) 46
6.3.2 North America Influenza Vaccine Revenue by Country (2017-2028) 47
6.3.3 U.S. 48
6.3.4 Canada 48
6.3.5 Mexico 49
7 EUROPE 50
7.1 Europe Influenza Vaccine Market Size by Type 50
7.1.1 Europe Influenza Vaccine Sales by Type (2017-2028) 50
7.1.2 Europe Influenza Vaccine Revenue by Type (2017-2028) 51
7.2 Europe Influenza Vaccine Market Size by Application 52
7.3 Europe Influenza Vaccine Market Size by Country 53
7.3.1 Europe Influenza Vaccine Sales by Country (2017-2028) 53
7.3.2 Europe Influenza Vaccine Revenue by Country (2017-2028) 54
7.3.3 Germany 55
7.3.4 France 56
7.3.5 U.K. 56
7.3.6 Italy 57
7.3.7 Russia 57
8 ASIA PACIFIC 58
8.1 Asia Pacific Influenza Vaccine Market Size by Type 58
8.1.1 Asia Pacific Influenza Vaccine Sales by Type (2017-2028) 58
8.1.2 Asia Pacific Influenza Vaccine Revenue by Type (2017-2028) 59
8.2 Asia Pacific Influenza Vaccine Market Size by Application 60
8.3 Asia Pacific Influenza Vaccine Market Size by Region 61
8.3.1 Asia Pacific Influenza Vaccine Sales by Region (2017-2028) 61
8.3.2 Asia Pacific Influenza Vaccine Revenue by Region (2017-2028) 62
8.3.3 China 64
8.3.4 Japan 64
8.3.5 South Korea 65
8.3.6 India 65
8.3.7 Australia 66
8.3.8 Southeast Asia 66
9 SOUTH AMERICA 67
9.1 South America Influenza Vaccine Market Size by Type 67
9.1.1 South America Influenza Vaccine Sales by Type (2017-2028) 67
9.1.2 South America Influenza Vaccine Revenue by Type (2017-2028) 68
9.2 South America Influenza Vaccine Market Size by Application 69
9.3 South America Influenza Vaccine Market Size by Country 70
9.3.1 South America Influenza Vaccine Sales by Country (2017-2028) 70
9.3.2 South America Influenza Vaccine Revenue by Country (2017-2028) 71
9.3.3 Brazil 72
10 MIDDLE EAST AND AFRICA 73
10.1 Middle East and Africa Influenza Vaccine Market Size by Type 73
10.1.1 Middle East and Africa Influenza Vaccine Sales by Type (2017-2028) 73
10.1.2 Middle East and Africa Influenza Vaccine Revenue by Type (2017-2028) 74
10.2 Middle East and Africa Influenza Vaccine Market Size by Application 75
10.3 Middle East and Africa Influenza Vaccine Market Size by Country 76
10.3.1 Middle East and Africa Influenza Vaccine Sales by Country (2017-2028) 76
10.3.2 Middle East and Africa Influenza Vaccine Revenue by Country (2017-2028) 77
10.3.3 Middle East 79
10.3.4 Africa 79
11 CORPORATE PROFILE 80
11.1 Sanofi 80
11.1.1 Sanofi Corporation Information 80
11.1.2 Sanofi Overview 80
11.1.3 Sanofi Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 81
11.1.4 Sanofi Influenza Vaccine Product Introduction 81
11.1.5 Sanofi Recent Developments 83
11.2 CSL 84
11.2.1 CSL Corporation Information 84
11.2.2 CSL Overview 84
11.2.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 85
11.2.4 CSL Influenza Vaccine Product Introduction 86
11.2.5 CSL Recent Developments 86
11.3 GSK 88
11.3.1 GSK Corporation Information 88
11.3.2 GSK Overview 89
11.3.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 89
11.3.4 GSK Influenza Vaccine Product Introduction 90
11.4 Viatris 91
11.4.1 Viatris Corporation Information 91
11.4.2 Viatris Overview 92
11.4.3 Viatris Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 92
11.4.4 Viatris Influenza Vaccine Product Introduction 93
11.4.5 Viatris Recent Developments 93
11.5 AstraZeneca 94
11.5.1 AstraZeneca Corporation Information 94
11.5.2 AstraZeneca Overview 95
11.5.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 95
11.5.4 AstraZeneca Influenza Vaccine Product Introduction 96
11.5.5 AstraZeneca Recent Developments 97
11.6 Hualan Bio 97
11.6.1 Hualan Bio Corporation Information 97
11.6.2 Hualan Bio Overview 98
11.6.3 Hualan Bio Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 99
11.6.4 Hualan Bio Influenza Vaccine Product Introduction 99
11.7 Changchun Institute of Biological 100
11.7.1 Changchun Institute of Biological Corporation Information 100
11.7.2 Changchun Institute of Biological Overview 101
11.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 102
11.7.4 Changchun Institute of Biological Influenza Vaccine Product Introduction 102
11.7.5 Changchun Institute of Biological Recent Developments 103
11.8 Sinovac 103
11.8.1 Sinovac Corporation Information 103
11.8.2 Sinovac Overview 104
11.8.3 Sinovac Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 104
11.8.4 Sinovac Influenza Vaccine Product Introduction 104
11.8.5 Sinovac Recent Developments 106
11.9 BCHT 106
11.9.1 BCHT Corporation Information 106
11.9.2 BCHT Overview 107
11.9.3 BCHT Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 108
11.9.4 BCHT Influenza Vaccine Product Introduction 108
11.9.5 BCHT Recent Developments 109
11.10 Jiangsu GDK 110
11.10.1 Jiangsu GDK Corporation Information 110
11.10.2 Jiangsu GDK Overview 111
11.10.3 Jiangsu GDK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 112
11.10.4 Jiangsu GDK Influenza Vaccine Product Introduction 112
11.11 KM Biologics 113
11.11.1 KM Biologics Corporation Information 113
11.11.2 KM Biologics Overview 113
11.11.3 KM Biologics Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 115
11.11.4 KM Biologics Influenza Vaccine Product Introduction 115
11.11.5 KM Biologics Recent Developments 116
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 118
12.1 Influenza Vaccine Industry Chain Analysis 118
12.2 Influenza Vaccine Key Raw Materials 119
12.2.1 Key Raw Materials 119
12.2.2 Raw Materials Key Suppliers 119
12.3 Influenza Vaccine Production Mode & Process 121
12.4 Influenza Vaccine Sales and Marketing 122
12.4.1 Influenza Vaccine Sales Channels 122
12.4.2 Influenza Vaccine Distributors 123
12.5 Influenza Vaccine Customers 125
13 INFLUENZA VACCINE MARKET DYNAMICS 129
13.1.1 Influenza Vaccine Industry Trends 129
13.1.2 Influenza Vaccine Market Drivers 130
13.1.3 Influenza Vaccine Market Challenges 131
13.1.4 Influenza Vaccine Market Restraints 131
14 KEY FINDINGS IN THE GLOBAL INFLUENZA VACCINE STUDY 132
15 APPENDIX 134
15.1 Research Methodology 134
15.1.1 Methodology/Research Approach 134
15.1.2 Data Source 137
15.2 Author Details 140
15.3 Disclaimer 140